Literature DB >> 27134624

Rare diseases in orthopedics: algodystrophy and aseptic osteonecrosis.

Giovanni Iolascon1, Umberto Tarantino2.   

Abstract

Entities:  

Year:  2016        PMID: 27134624      PMCID: PMC4832401     

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


× No keyword cloud information.
  6 in total

Review 1.  Nontraumatic necrosis of bone (osteonecrosis).

Authors:  H J Mankin
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

Review 2.  Rare diseases, orphan drugs, and their regulation in Asia: Current status and future perspectives.

Authors:  Peipei Song; Jianjun Gao; Yoshinori Inagaki; Norihiro Kokudo; Wei Tang
Journal:  Intractable Rare Dis Res       Date:  2012-02

Review 3.  Current concepts on osteonecrosis of the femoral head.

Authors:  Joaquin Moya-Angeler; Arianna L Gianakos; Jordan C Villa; Amelia Ni; Joseph M Lane
Journal:  World J Orthop       Date:  2015-09-18

Review 4.  Complex regional pain syndrome: An optimistic perspective.

Authors:  Frank Birklein; Darragh O'Neill; Tanja Schlereth
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

Review 5.  Osteonecrosis: current perspectives on pathogenesis and treatment.

Authors:  C C Chang; A Greenspan; M E Gershwin
Journal:  Semin Arthritis Rheum       Date:  1993-08       Impact factor: 5.532

Review 6.  Diagnostic use of skeletal survey in suspected skeletal dysplasia.

Authors:  Amith Kumar Iynapillai Veeramani; Paul Higgins; Sandra Butler; Malcolm Donaldson; Elizabeth Dougan; Roderick Duncan; Victoria Murday; Syed Fasial Ahmed
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-11-04
  6 in total
  1 in total

1.  Disease awareness or subtle product placement? Orphan diseases featured in the television series "House, M.D." - a cross-sectional analysis.

Authors:  Konstantin Mechler; Juliane Rausch; William K Mountford; Markus Ries
Journal:  BMC Med Ethics       Date:  2020-03-14       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.